Capturing the “Patient Voice” in Health Care

Published May 22, 2017
Presentation Explores Methods to Best Quantify Patient Input Boston, MA—May 22, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted a session at its 22nd Annual International Meeting that explored what methods researchers and health technology assessors should employ to best capture the patient voice in HEOR research. The issue panel held this afternoon in Boston, MA, USA, Voices and Echoes: What Methods Should We Be Using to Capture the Patient Voice [IP5], was moderated by Alaa Hamed, MD, MPH, MBA, Business Partner–Rare Disease, Health Economics and Outcomes Research, Sanofi Genzyme, Cambridge, MA, USA. Panelists included:
  • Kevin Marsh, PhD, Executive Director, Evidera Ltd, London, UK
  • Chad Gwaltney, PhD, Principal Consultant, Gwaltney Consulting, Westerly, RI, USA
  • John F. P. Bridges, PhD, Associate Professor, Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
While many health care stakeholders agree about the importance of involving patients in the process of health technology assessment, much debate still exists over how to best achieve this objective. For example, today there is no consensus as to what methodology should be used to capture the patient voice and in which circumstances these methods should be applied. The panel debated the pros and cons of different methodological approaches to incorporate and quantify patient input by reviewing three distinct approaches: 1) multiple criteria decision analysis (presented by Kevin Marsh, PhD), 2) patient-reported outcomes methods (presented by Chad Gwaltney, PhD), and 3) proposed stated preference methods (presented by John F. P. Bridges, PhD). The panel also briefly discussed other methods that have been put forward, such as analysis of social media data. Additional information on the ISPOR 22nd Annual International Meeting can be found here. Released presentations from the conference can be found here. Interested parties can follow conference news at ISPOR’s press site and on social media using the conference hashtag #ISPORBoston.

###

  ABOUT ISPOR The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB

Related Stories

ISPOR Announces Patient-Centered Research Summit 2024

Apr 23, 2024

ISPOR announced the sessions and speakers for its Patient-Centered Research Summit 2024. The Summit is scheduled to be held May 5 in Atlanta, GA, USA and is co-located with the Society’s annual international conference, ISPOR 2024.

ISPOR 2024 Plenaries and Speakers Announced

Apr 22, 2024

ISPOR announced the plenary sessions and speakers for ISPOR 2024, its annual international conference and the leading global conference for health economics and outcomes research (HEOR). ISPOR 2024 will be held May 5-8 in Atlanta, GA, USA.

ISPOR Global Panel Proposes New Structure to Improve Definitions of Digital Health Interventions

Apr 9, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the publication of a report from the ISPOR Digital Health Special Interest Group that proposes a new framework to help standardize and clarify definitions used for digital health interventions. The report, “The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report” was published in the April 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×